Loading Now

Granules India’s Q3 net down 6% at ₹117 crore

Granules India’s Q3 net down 6% at ₹117 crore


Granules India’s net profit declined 6 per cent at ₹117 crore in the third quarter ended December 2024 compared to ₹125 crore in the corresponding quarter of previous financial year. 

Revenues of the Hyderabad-based drugmaker too decreased 2 per cent at ₹1,137 crore as against ₹1,150 crore in the same period last year. 

Finished dosages (FD), Active Pharmaceuticals Ingredients (API) and pharmaceutical formulation intermediates (PFI) contributed 76 per cent, 12 per cent and 12 per cent of revenue from operations respectively in the quarter under review. 

The company voluntarily paused the production at the Gagillapur plant in September last year for risk assessment on account of the US FDA observations. Subsequently, the production resumed in October in a staggered manner, according to a release. 





Source link

Post Comment